- Pfizer (Cambridge, MA)
- …the development strategy for programs within the Late - Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for assigned ... studies maintaining current scientific and clinical knowledge in the specific therapeutic and disease area(s)... Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and… more
- Bristol Myers Squibb (Cambridge, MA)
- …understanding of disease biology, mechanism of action, and predictive biomarkers in our late - stage clinical oncology portfolio. Ideal candidates will ... a matrixed industrial environment. Seeking candidates with Biomarker Lead late stage clinical trials for...tumor-immunology disease biology + In-depth understanding of solid tumor oncology with knowledge of current and evolving clinical… more
- Bristol Myers Squibb (Cambridge, MA)
- …Development is part of the Global Research organization in BMS and leads late stage clinical , pharmacological and translational research and development ... neuroscience with 7+ years of translational medicine experience + 5+ years of late - stage clinical biomarker experience in biotech/pharma + Recognized… more
- Sumitomo Pharma (Boston, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Bristol Myers Squibb (Cambridge, MA)
- …human through proof of concept trials and will to assure a seamless transition into late stage development (Phase II-III trials) + Ability to lead and develop a ... at work and in their personal lives. Read more: careers.bms.com/working-with-us . The Clinical Development Lead sits within Clinical Development, which is a… more
- Takeda Pharmaceuticals (Boston, MA)
- …strategies. You will set global regulatory direction, provide expert guidance, and lead late - stage projects to ensure innovative and robust strategies are in ... tactical regulatory insight on one or multiple complex global oncology projects in clinical development with focus...authoring, or managing components of regulatory submissions including for Late - Stage assets. + Solid working knowledge of… more
- Sumitomo Pharma (Boston, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Marlborough, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Takeda Pharmaceuticals (Boston, MA)
- …Clinical Lead a large solid tumor oncology franchise that encompass multiple late stage and early phase programs . Ensures ongoing review and agreement of ... + ** Clinical Development team participation and leadership** + Accountable to Oncology Clinical Science Head to provide strategic clinical input… more
- Sumitomo Pharma (Boston, MA)
- …Experience in conducting global clinical trials in both early- and late - stage clinical development, especially protocol development and trial initiation ... study concept to clinical study protocol for both early- and late - stage programs + Leads or joins multi-disciplinary, multi-regional, matrix team through… more
- Sumitomo Pharma (Boston, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... motivated, and experienced individual for the position of **Associate** **Medical Director, Clinical Development - Oncology ** . The associate medical director is… more
- Bristol Myers Squibb (Cambridge, MA)
- …through proof of concept trials and will assure a seamless transition into late stage development (Phase II-III trials.) **Governance Participation and Signature ... and franchise aspects for potential in-licensing opportunities that shape the oncology clinical development strategy **Key Competency Requirements:** + Proven… more
- Takeda Pharmaceuticals (Cambridge, MA)
- …knowledge and experience in clinical pharmacology responsibilities in early & late stage and post-marketing studies. + Formulates and executes clinical ... will inspire you and empower you to shine? Join us as Director, Quantitative Clinical Pharmacology (QCP) Lead in our Cambridge, MA office. Our Data and Quantitative… more
- Sumitomo Pharma (Boston, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... a primary focus on advancing translational research to support oncology programs in clinical trial stages. This...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Takeda Pharmaceuticals (Boston, MA)
- …be to drive efficient and effective CDx strategy execution for early- and late - stage Oncology programs. Key responsibilities include development and delivery ... etc). This role will partner closely with key functions across Takeda Oncology including Translational Medicine, Clinical Sciences, Global Regulatory Affairs,… more
- Sumitomo Pharma (Boston, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Boston, MA)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Boston, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Sumitomo Pharma (Boston, MA)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more